627
Participants
Start Date
July 31, 2003
Primary Completion Date
August 31, 2006
Study Completion Date
August 31, 2006
5 FU
As prescribed, in 2 week cycles
Leucovorin
As prescribed, in 2 week cycles
Oxaliplatin
As prescribed, in 3 week cycles
Oxaliplatin
As prescribed, in 2 week cycles
capecitabine [Xeloda]
1000mg/m2 po bid on days 1-15 of each 3 week cycle
Taipei
Tainan City
Brussels
Ljubljana
Brussels
Pietermaritzburg
Durban
Mont-godinne
Port Elizabeth
Cape Town
Kortrijk
Ghent
Zagreb
Nyack
Belgrade
Turku
Split
Bergamo
Madrid
Madrid
Leganés
Nîmes
Bordeaux
Bordeaux
Udine
Pessac
Tampere
Chambray-lès-Tours
Kfar Saba
Terre Haute
Cattolica
Rimini
Petah Tikva
Ramat Gan
Thessaloniki
Billings
St Louis
Heraklion
Tübingen
Dallas
Rouen
Rehovot
Colorado Springs
Avignon
Limoges
Jerusalem
Bakersfield
Tel Aviv
Beersheba
Washington D.C.
Edmonton
St. John's
Halifax
London
Oshawa
Ottawa
Saint Catherines
Thunder Bay
Toronto
Weston
Laval
Lévis
Montreal
Montreal
Montreal
Québec
Regina
Bialystok
Krakow
Warsaw
Warsaw
San Juan
Bratislava
Pretoria
Buchun
Seoul
Seoul
Seoul
Seoul
Seoul
Barcelona
Palma de Mallorca
Kueishan
Denbigh
Manchester
Merseyside
Preston
Hoffmann-La Roche
INDUSTRY